Author: Rahul Gosain, MD, MBA

Video

5 Key GI Cancer Updates From ESMO 2025

Rachna Shroff, MD, MS, FASCO | Rohit Gosain, MD | Rahul Gosain, MD, MBA

Video

8 Practice-Changing Breast Cancer Presentations From ESMO 2025

Virginia Kaklamani, MD, DSc | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Video

Top 5 GU Oncology Presentations From ESMO Congress 2025

Stephanie Berg, DO | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Video

Unraveling the Treatment Algorithm for Ovarian Cancer

Sharyn N. Lewin, MD | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Video

Treating Complex Cases of EGFR-Mutated NSCLC

Eric Singhi, MD | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Video

Key Takeaways From IMforte for Clinicians Treating ES-SCLC

Ticiana Leal, MD | Stephen Liu, MD | Isabel Preeshagul, DO, MBS | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Video

Sequencing Lurbinectedin in ES-SCLC with CNS Involvement

Ticiana Leal, MD | Stephen Liu, MD | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Video

Managing Side Effects of CDK4/6 Inhibitors in Breast Cancer

Stephanie Graff, MD, FACP, FASCO | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Video

Managing Lurbinectedin Adverse Events in ES-SCLC Maintenance Therapy

Isabel Preeshagul, DO, MBS | Stephen Liu, MD | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Video

Treating CML in 2025: TKIs and Transplant

Jorge Cortes, MD | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Video

Clinical Relevance of IMforte Survival Data in ES-SCLC

Ticiana Leal, MD | Stephen Liu, MD | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Video

Efficacy Outcomes in the IMforte Trial: PFS, OS, and Clinical Impact

Stephen Liu, MD | Rahul Gosain, MD, MBA | Rohit Gosain, MD